Wildflower Brands Inc. Stock Canadian Securities Exchange
Equities
SUN
CA96812N1050
Pharmaceuticals
Sales 2018 | 1.41 1.92 | Sales 2019 | 7.09 9.64 | Capitalization | 63.9M 86.96M |
---|---|---|---|---|---|
Net income 2018 | -7M -9.53M | Net income 2019 | -4M -5.44M | EV / Sales 2018 | 44,908,398 x |
Net Debt 2018 | 7.85M 10.69M | Net Debt 2019 | 7.32M 9.96M | EV / Sales 2019 | 10,051,719 x |
P/E ratio 2018 |
-6.99
x | P/E ratio 2019 |
-6.61
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 14-06-17 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 13-08-29 |
Myron van Snick
COO | Chief Operating Officer | - | 20-04-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 13-08-29 |
William MacLean
CEO | Chief Executive Officer | - | 14-06-17 |
Director/Board Member | - | 18-04-05 |
1st Jan change | Capi. | |
---|---|---|
+42.38% | 6.26B | |
-15.86% | 4.49B | |
+6.36% | 3.29B | |
-11.28% | 3.12B | |
-3.23% | 2.5B | |
+45.24% | 1.94B | |
-7.89% | 1.68B | |
-0.98% | 1.63B | |
-11.32% | 1.56B |